Newest first
New topics page 30
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 30 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a…
|
+64 | 69 | 15k | 7mo |
|
A friction point in the promotion workflow
A friction point in the promotion workflow — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps…
|
+4 | 8 | 491 | 11mo |
|
Immortal time bias in a claims-database study
Immortal time bias in a claims-database study — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim I do not think it…
|
+29 | 34 | 28k | 11mo |
|
Follow-up: Why appetite effects are mostly central
Asking directly, because I could not find a straight answer: Why appetite effects are mostly central A documentation question rather than an analytical one. I have a certificate in front of me that reports a…
|
+86 | 90 | 61k | 9mo |
|
Rewriting my first post: a before-and-after, with commentary
Rewriting my first post: a before-and-after, with commentary Writing it up because I had to work it out twice and would rather nobody else did. I want to check my reasoning rather than get a conclusion. My…
|
3 | 2.7k | 4mo | |
|
Follow-up: Why we hide unevidenced fraud accusations and log the hiding
The question in the title: Why we hide unevidenced fraud accusations and log the hiding I will give what I have already checked below so nobody repeats it. Structured report rather than an opinion, following…
|
+12 | 16 | 17k | 12mo |
|
Why catalogue breadth is not evidence of anything — what changed since
Asking directly, because I could not find a straight answer: Why catalogue breadth is not evidence of anything — what changed since Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
+62 | 66 | 26k | 10mo |
|
A field-by-field walk through a certificate of analysis
Posting this under the heading it deserves: A field-by-field walk through a certificate of analysis Everything below is what sits behind that. A documentation question rather than an analytical one. I have a…
|
+136 | 147 | 1.8k | 12mo |
|
Appeal templates and why they are deliberately unemotional — one year on
Appeal templates and why they are deliberately unemotional — one year on Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because…
|
2 | 4.1k | 11mo | |
|
A calculator that gives a right answer to the wrong question — does this still hold?
A calculator that gives a right answer to the wrong question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what…
|
+23 | 27 | 62k | 8mo |
|
Measurement error in home scales, with a worked standard deviation — a second dataset
Measurement error in home scales, with a worked standard deviation — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with SURPASS-2…
|
2 | 13k | 7mo | |
|
Second pass at: What "verified" means on our vendor pages, stated narrowly
Second pass at: What "verified" means on our vendor pages, stated narrowly — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better…
|
+94 | 102 | 20k | 3mo |
|
Revisiting: Review: an evidence digest and the citation check that delayed it
Revisiting: Review: an evidence digest and the citation check that delayed it — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation…
|
+54 | 58 | 8.2k | 5mo |
|
Theoretical plates: useful number or ritual?
Theoretical plates: useful number or ritual? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means before I repeat it…
|
2 | 284 | 9mo | |
|
Guidelines revision: what changed and why — one year on
On the subject in the title: Guidelines revision: what changed and why — one year on Working notes rather than a conclusion. Process question about how this site works. I have read the guidelines and the…
|
+75 | 81 | 3.9k | 4mo |
|
About the Trials category
Individual randomised trials: design, population, endpoints, results, and limitations. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+6 | 10 | 27k | 12mo |
|
Angle of injection and whether 90 degrees is always right
On the subject in the title: Angle of injection and whether 90 degrees is always right Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful to…
|
+105 | 116 | 5.4k | 4mo |
|
Second pass at: How to ask a question when you cannot say why you are asking it
Second pass at: How to ask a question when you cannot say why you are asking it — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to…
|
+73 | 81 | 16k | 4mo |
|
The nausea timeline across the first four weeks, with a tabulated log — what changed since
On the subject in the title: The nausea timeline across the first four weeks, with a tabulated log — what changed since Working notes rather than a conclusion. I have read the maintained page on this and I…
|
+24 | 29 | 2.8k | 6mo |
|
Why semaglutide solutions can look faintly opalescent and when that matters
The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats it. Comparing LEADER ( N Engl J Med ,…
|
+73 | 79 | 2k | 4mo |
|
Revisiting: Early satiety becoming a problem rather than a benefit
On the subject in the title: Revisiting: Early satiety becoming a problem rather than a benefit Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing the…
|
2 | 14k | 12mo | |
|
[2026 update] A single out-of-range value on an otherwise normal panel
On the subject in the title: A single out-of-range value on an otherwise normal panel Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the…
|
+15 | 19 | 53k | 9mo |
|
Coming back to: A community side-effect dataset, with its response rate and biases
On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Posting the method first, because I know what the first three replies…
|
+27 | 31 | 46k | 9mo |
|
Dose numbers across compounds are not on the same scale
Dose numbers across compounds are not on the same scale — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I am asking…
|
2 | 1.6k | 9mo | |
|
DXA precision and the least significant change for lean mass — what changed since
DXA precision and the least significant change for lean mass — what changed since — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this…
|
2 | 56k | 11mo | |
|
Trust level 3 requirements: a clarification
Trust level 3 requirements: a clarification — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps…
|
+10 | 14 | 7k | 9mo |
|
Thyroid function tests during substantial weight change
Posting this under the heading it deserves: Thyroid function tests during substantial weight change Everything below is what sits behind that. General question, not a request for advice about my own care — I…
|
+136 | 149 | 3.3k | 8mo |
|
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists
Posting this under the heading it deserves: Nausea profile of amylin analogues compared with GLP-1 agonists Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with FLOW ( N Engl…
|
+48 | 53 | 31k | 13mo |
|
Discussing something you have already been doing — the long version
Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+14 | 18 | 58k | 12mo |
|
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
|
4 | 62k | 9mo |